The effect of a single administration of aromatic hydrocarbons (AHCs) on the metabolic activity responsible for the biotransformation of dichloromethane (DCM) to carbon monoxide (CO) was investigated using adult female rats. In rats treated orally with benzene (1.5 ml kg-'), toluene (2.0 ml kg-') or m-xylene (2.0 ml kg-I) 1 6 2 4 h prior to DCM (3 mmol kg-', i.p.), the carboxyhaemoglobin (COHb) level was elevated, reaching peaks in blood at 21%, 16% and 23%, respectively, compared to the peak of ca. 10% in rats treated with DCM only. Their effects on COHb generation were highly dependent on the time interval between each AHC and DCM treatment, since an early administration of m-xylene or toluene decreased the COHb elevation. The half-life of DCM in blood was shortened significantly, indicating that the metabolic degradation of DCM was enhanced by the AHCs. Disulfiram (3.4 mmol kg-I, p.0.) blocked COHb elevation completely, suggesting that the metabolic conversion of DCM to CO is mediated by cytochrome P-450 2E1 (P4502E1). Corresponding increases in the concentration and half-life of DCM in blood were also observed. A single administration of the AHCs did not alter the hepatic glutathione level, suggesting that the increase in DCM-induced COHb elevation was not due to hepatic glutathione depletion. In vitro studies showed that the hepatic microsomal metabolism of nitrosodimethylamine and p-nitrophenol was significantly increased by a single dose of each AHC. Total cytochrome P-450 content and p-nitroanisole demethylase activity were also increased; however, only toluene and m-xylene were effective inducers for aminopyrine N-demethylase. Therefore, benzene appears to be a selective inducer for P4502E1 compared to other alkylbenzenes. The results indicate that even a single dose of benzene, toluene or m-xylene may induce the activity of P4502E1 significantly, which is responsible for the increased generation of COHb from DCM, as demonstrated in the present study.
INTRODUCTION
Dichloromethane (DCM) is a solvent used widely in removing paints, degreasing, extracting foods, manufacturing plastics and other purposes. This solvent is considered to be relatively non-toxic compared to other halogenated hydrocarbons, such as chloroform or carbon tetrachloride.' However, exposure to DCM results in the formation of carbon monoxide (CO) during its biotran~formation.~~ Metabolism to CO is mediated by the microsomal fraction of liver and requires NADPH and molecular ~x y g e n .~.~ On the other hand, in the cytosolic fraction, a glutathione-dependent pathway produces carbon dioxide (CO,) from DCM.6 This pathway showed no indication of saturation at inhaled concentrations of DCM up to 10000 ppm.' However, the carboxyhaemoglobin (COHb) formation caused by the microsomal monooxygenase reactions has been reported to be saturable, reaching a maximum COHb level of ca. 10% in blood.8 Prior administrations of phenobarbital or 3-rnethylcholanthrene produced no t Author to whom correspondence should be addressed. appreciable alterations in DCM-induced COHb levels.' Also, SKF 525-A or cobaltous chloride failed to alter COHb level^.^.'^ The reasons for saturable metabolism of DCM to CO and its inertness to a metabolic inducer or inhibitor remain unknown. Recently it has been suggested that cytochrome P-450 2E1 (P4502El) is a subtype of the cytochrome P-450 family responsible for the metabolic conversion of DCM to CO."
Benzene, toluene and rn-xylene are small aromatic hydrocarbon (AHC) solvents of industrial and environmental significance. They are used in many industrial processes and found as a constituent of gasoline, paints, adhesives, inks and cleaning agents. It has been shown that some of the AHCs may induce cytochrome P-450 and subsequently stimulate cytochrome P-450-dependent metabolic reactions. The hydroxylation of p-nitrophenol was increased in rabbits treated with benzene for 3 days." Toluene or rn-xylene has also been shown to be an effective inducer of cytochrome P-450 and associated monooxygenase activities. Toluene induces the microsomal metabolism of aniline and aminopyr i r~e . '~-'~ A m ixture of xylene isomers was shown to induce the major phenobarbital-inducible cytochrome P-450 isozymes.16 But their effect on the P4502E1 subtype is still u n~l e a r . '~. '~ S . K. KIM AND Y. C. KIM The present study was undertaken to determine the effects of a single treatment of AHC on the CO generation from DCM, and also to characterize the enzyme system responsible for this metabolic conversion. Since both DCM and AHCs are widely used volatile solvents, a combined exposure of workers to these chemicals may be a frequent occurrence in workplaces.
EXPERIMENTAL Chemicals
Drugs and chemicals used in this study include benzene (Shinyo Pure Chemicals Co., Osaka, Japan), toluene (Fluka AG, Buchs, Switzerland), sodium dithionite and dichloromethane (Fisher Scientific Co., Fair Lawn, NJ, USA), m-xylene (Junsei Chemical Co., Tokyo, Japan), p-nitrophenol, nitrosodimethylamine and aminopyrine (Sigma Chemical Co., St. Louis, MO, USA) and formaldehyde and p-nitroanisole (Aldrich-Chemie, Steinheim, Germany). All other chemicals and solvents were reagent grade or better.
Animals and treatments
Female Sprague-Dawley rats (1 80-200 g) were used throughout the study. Animals were acclimatized in environmentally controlled rooms (light: 07.00-19.00 h; dark: 19.00-07.00 h) for at least 4 weeks prior to experimentation. Laboratory chow and tapwater were allowed ad libitum. Benzene (1.5 ml kg-'), toluene (2.0 ml kg-I), m-xylene (2.0 ml kg-') or disulfiram (3.4 mmol kg-I) was dissolved or suspended in corn oil. These chemicals were administered intragastrically in a volume of 7.5 ml kg-I. Control rats received a comparable volume of corn oil. Dichloromethane (3 mmol kg-I) was dissolved in corn oil and administered to the rats intraperitoneally.
Measurement of COHb and DCM in blood
Blood samples were withdrawn from a retroorbital venous plexus and collected in heparinized tubes. The COHb concentration in blood was determined using a modification of the method of Rodkey et a1.I9 Each blood sample was diluted ca. 1500-fold with 0.01 M TRIS solution containing sodium dithionite to prevent dissociation of COHb by oxygen. Absorbance measurements were made at 420 and 432nm in a Beckman DU 650 spectrophotometer (Beckman Instruments Inc., Irvine, CA, USA). The fraction of the total haemoglobin present as COHb was calculated from these measurements using molar absorptivities of haemoglobin and carboxyhaemoglobin.
The DCM levels in blood were determined using a modification of the method previously reported. lo Each blood sample stood at room temperature for 60 min before the head-space vapour was injected into a Varian Model 3300 gas chromatograph (Varian Instruments Division, Palo Alto, CA, USA) equipped with a flame ionization detector. A 6 ft X 2 mm-i.d. stainless-steel 10% OV-101 column was used. Nitrogen was the carrier gas (30ml min-I), and air (300ml min-l) and hydrogen (30 ml min-') were utilized in the flame ionization detector. The column was set at 100°C, the detector at 250°C and the injector port at 240°C.
Measurement of hepatic glutathione content
After euthanization of an animal, the liver was perfused with saline before being removed. The liver was homogenized in a four-fold volume of cold 1 M perchloric acid solution with 2 mM EDTA. After the denatured protein was removed by centrifugation at 5000 g for 5 min, the supernatant was assayed for reduced glutathione content accoding to the method of Griffith.20 
Microsomal enzyme assays
Rats were forced to fast for 16 h prior to sacrifice. The liver was homogenized in a three-fold volume of an ice-cold buffer consisting of 0.154 M KCU50 mM TRIS-HCl and 1 mM EDTA (pH 7.4). All subsequent steps were performed at 0 4°C . The homogenate was centrifuged at 12 000 g for 20 min. The 12 000 g supernatant fraction was further centrifuged at 104 000 g for 60 min. The microsomal pellet was resuspended in the cold buffer and recentrifuged at 104 000 g for 60 min. The microsomes were diluted to an equivalent of 0.5 g liver ml-' buffer. Protein content was measured by the method of Lowry et aL2I
The concentration of cytochrome P-450 was estimated from the CO difference spectrum, and the cytochrome bs content from the NADH difference spectrum of the microsomal suspension. 22 p-Nitrophenol (PNP) hydroxylase activity was determined by measuring the formation of p-nitrocate~h o l . '~ Reaction mixtures (final vohme of I ml) contained 0.1 mM p-nitrophenol, 1 .O mM ascorbic acid, 0.1 ml of microsomal suspension and 1 mM NADPH in 0.1 M potassium phosphate buffer (pH 6.8). Incubation was initiated with addition of NADPH (after a 2-min preincubation period). The temperature was maintained at 37°C. Reaction was terminated by addition of 0.5 ml of ice-cold 10% perchloric acid after a 3-min incubation period.
Aminopyrine (AM) N-demethylase activity and nitrosodimethylamine (NDMA) N-demethylase activity were determined by measuring the formaldehyde prod~ction.'~ The amount of p-nitrophenol formed was measured for p-nitroanisole (PNA) 0-demethylase activity." Reaction mixtures consisted of 0.1 ml of microsomal suspension, 1 mM NADPH, the substrate (5 mM for NDMA and aminopyrine; 0.1 mM for pnitroanisole) and 0.1 M potassium phosphate buffer (pH 7.4), in a total volume of 1.0 ml. Incubation was initiated with addition of NADPH (after a 2-min preincubation period) and carried at 37°C. Reaction was terminated by addition of 0.3 ml of ice-cold 20% trichloroacetic acid after a 10-min incubation period.
Data analysis
All results expressed as means 2 SEM were analysed by a two-tailed Student's t-test or one-way analysis of variance (ANOVA). The acceptable level of significance was established at P < 0.05, except when other-wise indicated. The half-life of DCM was determined by linear regression of log blood concentrations of DCM vs time for each animal.
RESULTS

Effect of AHCs on COHb levels induced by DCM
A 3 mmol kg-' dose of DCM caused a significant increase in COHb concentrations, reaching a peak of ca. 10% 2-3 h after administration (Fig. 1) . The COHb levels returned to normal 3 or 4 h after reaching the peak in blood. Doubling the DCM dose from 3 to 6 mmol kg-' failed to show a corresponding increase in the peak COHb level, suggesting that the metabolism of DCM to COHb was saturated at the lower dose (data not shown). In subsequent experiments, benzene (1.5 ml kg-I), toluene (2.0 ml kg-') or rn-xylene (2.0 ml kg-') was administered 16, 20 and 24 h prior to DCM. The DCM-induced COHb formation was significantly enhanced by a prior administration of each aromatic hydrocarbon solvent (Fig. lA, B, C) . In rats pretreated orally with benzene, toluene or rn-xylene, the maximum COHb levels plateaued at 21%, 16% or 23%, respectively, compared to 10% in control rats treated with DCM only. However, their effects on the COHb elevation appear to be highly dependent on the time interval between each AHC and DCM treatment. The elevation of the DCM-induced COHb level by benzene, toluene or rn-xylene was maximal when each AHC was treated 16, 20-24 or 24 h prior to DCM administration, respectively. When DCM was administered 16 h after rn-xylene or toluene, the COHb formation was rather inhibited. In order to identify the metabolic activity responsible for the COHb formation from DCM, rats were pretreated with disulfiram (3.4 mmol kg-', p .~. ) , a selective inhibitor of P4502El. A single administration of disulfiram either 1 or 18 h prior to DCM completely blocked the increase in COHb levels (Fig. 1D) .
Effect of AHCs on half-life of DCM in blood
The effect of a small AHC treatment on the DCM concentration and half-life in blood was examined in rats. The DCM concentration in blood declined in a log-linear fashion (Table 1 ). In control animals DCM was eliminated from blood with a half-life of ca. 24 min. Treatment of rats with benzene 18 h prior to DCM significantly increased the rate of DCM disappearance from blood. The administration of toluene or rn-xylene also increased the rate of DCM elimination from blood. In contrast, disulfiram pretreatment 18 h prior to DCM increased the DCM levels in blood at all time points determined in this study. The half-life of DCM in blood was correspondingly prolonged to 39.4 min, indicating that the elimination of this volatile solvent is strongly influenced by its metabolic degradation to CO.
Effect of AHCs on hepatic glutathione content
Hepatic glutathione (GSH) plays an important role not only in the metabolic conversion of DCM to carbon dioxide (CO,) but also in the detoxification of some aromatic hydrocarbons, such as benzene. Therefore, the availability of hepatic GSH at the time of DCM challenge was determined in rats pretreated with an AHC (Fig. 2) . The hepatic reduced glutathione content in control rats was 6.8 pmol g-' liver, and the value in benzene-, toluene-or rn-xylene-treated rats was 6.1, 6.8 and 6.8 pmol g-' liver, respectively. It was concluded that in this study the AHC treatment did not decrease the concentrations of hepatic glutathione required for the metabolic degradation of DCM to CO,.
Effect of AHCs on microsomal enzyme activity
The effect of the small AHCs on selected microsomal monooxygenase activities was determined. A single administration of each AHC examined in this study significantly increased the cytochrome P-450 content in liver microsomes (Table 2 ). An elevation in cytochrome b, content was associated with the toluene or rn-xylene treatment only. The microsomal protein content was significantly increased by rn-xylene but not changed by either benzene or toluene. The oxidative reactions of substrates metabolized by cytochrome P-450 were also determined. The hydroxylation of pnitrophenol (PNP), a substrate considered to be highly sensitive for P4502E 1, was significantly elevated by benzene (240%), toluene (210%) and rn-xylene (280%). The demethylation of nitrosodimethylamine (NDMA), which is also associated with P4502E1 activity, was significantly increased to 140%, 130% or 120% of the control by benzene, toluene or rn-xylene, respectively. The AHCs all increased the p-nitroanisole (PNA) demethylase activity as well. The N-demethylation of aminopyrine (AM) was induced significantly by toluene or rn-xylene, but not affected by benzene. Since the benzene treatment increased the metabolic conversion of p-nitrophenol and nitrosodimethylamine without affecting the activity of aminopyrine N-demethylase, benzene appears to be a rather selective inducer for P4502E1. In contrast, both toluene and rn-xylene remarkably increased the activities of p-nitroanisole and aminopyrine demethylase, indicating that the effect of these alkylbenzenes is not limited to the activity of P4502E1 compared to that of benzene. 
Discussion
Dichloromethane is metabolized by two major pathways: an oxidative cytochrome P-450-mediated pathway that has been known to yield CO, and a glutathione-dependent pathway that yields C02.4,6 The metabolism of DCM to CO is mediated by the microsoma1 fraction of liver and requires NADPH and molecular ~x y g e n .~.~ It has been reported that pretreatment of rats with phenobarbital resulted in an increase in the conversion rate of DCM to CO in the microsomal fraction.4 However, the DCM-induced COHb formation was not altered by either phenobarbital or 3-methylcholanthrene.9 It was suggested that the failure was due to suppression of further CO generation resulting from inhibition of cytochrome P-450 activity by CO, a major metabolite of DCM.26 Also SKF 525-A (2-diethylaminoethyl 2,2-diphenylvalerate.HCl), a well-known drug metabolism inhibitor, or cobaltous chloride only minimally altered the elevation of COHb induced by DCM.9.'n But rats exposed for 1 h to either an atmosphere containing 8000 ppm ethanol or 1350 ppm isopropranol showed a significant inhibition of COHb formation caused by 5000ppm DCM inhaled at the same time." And an i.p. administration of methanol, toluene or pyrazole to rats 30 min prior to a DCM inhalation challenge decreased the COHb e l e~a t i o n . '~~~' In the present study a single administration of benzene, toluene or m-xylene significantly increased the formation of COHb induced by DCM. In the rats treated orally with one of the small AHCs 16-24 h prior to DCM administration, the peak COHb level was doubled compared to the rats treated with DCM only. The effect of an AHC on DCM-induced COHb levels was time dependent. When the rats were treated with rn-xylene 16 h prior to DCM administration, COHb generation was rather inhibited. Since both DCM and small AHCs are predominantly metabolized by the microsomal monooxygenase reactions, it appears that the competition between DCM and m-xylene for the same active site on the enzyme(s) may lead to inhibition of COHb formation. In fact rn-xylene in blood was detected by gas chromatography for at least 24 h following the administration of this solvent (unpublished observation). The elimination of DCM from blood was enhanced by each AHC treatment. In rats pretreated with one of the AHCs, the half-life of DCM in blood was shortened to ca. 18 min from 24 min and the DCM concentration in blood was also significantly reduced. The results suggest that the metabolism of DCM in viva was markedly increased by a single dose of the small AHCs.
The changes in DCM metabolism appear to be induced by altered activity of P4502E1, an isozyme of cytochrome P-450 which has been known to play an important role in the metabolism of this halogenated hydrocarbon.2R Disulfiram, an inhibitor for this specific type of i~o z y m e ,~~ blocked the DCM-induced COHb generation completely in the present study. Also, the corresponding elevation in the concentration and halflife of DCM in blood suggests that the increase in metabolism of DCM is associated with induction of the P4502E1 activity by an AHC treatment.
The other important metabolic pathway for DCM is glutathione-dependent formation of C 0 2 in the cytosolic fraction. Also, consumption of this endogenous tripeptide has been known to be critical in the detoxification of electrophilic metabolites from some xenobiotics. One example is arene oxides generated from aromatic compounds by the microsomal monooxygenase reactions. Since it was suspected that a decrease in hepatic glutathione resulting from the detoxification of an AHC could lead to a shift in the balance between the two metabolic pathways for DCM from the one dependent on this tripeptide to the microsomal reactions producing CO, the effect of the AHCs on hepatic glutathione levels was determined. However, the results indicate that none of the AHCs altered the availability of hepatic glutathione at the doses employed in the present study.
In order to elucidate the further mechanism for the potentiation of DCM-induced COHb elevation by the small AHCs, the effect of each alkylbenzene on the microsomal enzyme activities was examined. Benzene, toluene and m-xylene all increased the metabolic conversion of p-nitrophenol (PNP) and nitrosodimethylamine (NDMA), both considered to be selective substrates for P4502E1. Cytochrome P-450 contents and pnitroanisole demethylase activity were elevated by each of the small AHCs, with greatest induction shown by rn-xylene, followed by toluene and benzene. Both the activity of aminopyrine N-demethylase and the cytochrome b, contents were increased by either toluene or m-xylene but none were increased by benzene. mXylene alone increased the microsomal protein content and the relative liver weight as well. These results indicate that all the small AHCs examined in the present study induce the activity of P4502E1. However, benzene appears to be a rather selective inducer for this isozyme compared to other alkylbenzenes.
It has been reported that repeated treatment with small AHCs may alter the hepatic and extrahepatic microsomal enzyme activities. The metabolism of benzene, which has been shown to be mediated by P4502E1 , 30 was increased in rats following repeated administrations of several alkylbenzenes for 3 days. 13. In a kinetic study, it was found that repeated benzene exposure changed the plasma concentration of inhaled benzene.31 Also, hydroxylation of aniline was increased either by inhalation of toluene vapour or by repeated i.p. injections of xylenes for 3
Recently it was observed that both P4502E1 content and aniline metabolism were elevated in rats exposed to benzene, toluene or m-xylene by inhalation for 4 days.18 Among the AHCs examined, benzene was the most potent inducer, followed by toluene and m-xylene. However, not all experimental evidence supports the above observations. Repeated treatment of rats with small AHCs for 3 days failed to affect the NDMA metabolism and P4502E1 1evel.l' Also, benzene treatment for 3 or 4 days did not increase the activity of aniline hydroxylation, the level of P4502E1 or its own microsomal metabolism in rats.13*32*33 The reasons for the discrepancy between the two lines of observations remain unclear. However, the results in the present study indicate that the COHb production from DCM, which is dependent on the P4502E1 activity, is enhanced by one single dose of benzene, toluene or m-xylene. A single, acute administration of the small AHCs all induced the microsomal monooxygenase activities associated with this subtype of cytochrome P-450. Among the AHCs examined in this study, benzene appears to be a faster and more selective inducer for P4502El. This conclusion is partly supported by the observation of Saito el al., who found that a 24-h prior administration of benzene increased phenol production from the AHC in rat liver micro~ornes.~~ Of more practical importance is the significance that P4502E1 activity has in the metabolism of small molecular toxicants such as carbon tetra~hloride,'~ acetaminophed6 and nitro~odirnethylarnine.~' In fact we have recently reported that a single dose of benzene, toluene or m-xylene markedly potentiated the hepatotoxicity induced by carbon tetrachloride in rats3* Likewise, a small AHC given acutely may alter the metabolism of itself and various chemicals, and subsequently potentiate the chemical hazards in humans and animals.
